Global Bevacizumab Market Growth (Status and Outlook) 2019-2024

January 2019 | 116 pages | ID: G43CBF3734DEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Bevacizumab, sold under the trade name Avastin, is a medication used to treat a number of types of cancers and a specific eye disease.

According to this study, over the next five years the Bevacizumab market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Bevacizumab business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Bevacizumab market by product type, application, key companies and key regions.

This study considers the Bevacizumab value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.

• Avastin (bevacizumab)
• Mvasi (bevacizumab-awwb)

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.

• Cancer
• Eye Diease

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

• Genentech
• Amgen
• ...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Bevacizumab market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
• To understand the structure of Bevacizumab market by identifying its various subsegments.
• Focuses on the key global Bevacizumab players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Bevacizumab with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Bevacizumab submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Bevacizumab Market Size 2014-2024
  2.1.2 Bevacizumab Market Size CAGR by Region
2.2 Bevacizumab Segment by Type
  2.2.1 Avastin (bevacizumab)
  2.2.2 Mvasi (bevacizumab-awwb)
2.3 Bevacizumab Market Size by Type
  2.3.1 Global Bevacizumab Market Size Market Share by Type (2014-2019)
  2.3.2 Global Bevacizumab Market Size Growth Rate by Type (2014-2019)
2.4 Bevacizumab Segment by Application
  2.4.1 Cancer
  2.4.2 Eye Diease
2.5 Bevacizumab Market Size by Application
  2.5.1 Global Bevacizumab Market Size Market Share by Application (2014-2019)
  2.5.2 Global Bevacizumab Market Size Growth Rate by Application (2014-2019)

3 GLOBAL BEVACIZUMAB BY PLAYERS

3.1 Global Bevacizumab Market Size Market Share by Players
  3.1.1 Global Bevacizumab Market Size by Players (2017-2019)
  3.1.2 Global Bevacizumab Market Size Market Share by Players (2017-2019)
3.2 Global Bevacizumab Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BEVACIZUMAB BY REGIONS

4.1 Bevacizumab Market Size by Regions
4.2 Americas Bevacizumab Market Size Growth
4.3 APAC Bevacizumab Market Size Growth
4.4 Europe Bevacizumab Market Size Growth
4.5 Middle East & Africa Bevacizumab Market Size Growth

5 AMERICAS

5.1 Americas Bevacizumab Market Size by Countries
5.2 Americas Bevacizumab Market Size by Type
5.3 Americas Bevacizumab Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Bevacizumab Market Size by Countries
6.2 APAC Bevacizumab Market Size by Type
6.3 APAC Bevacizumab Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Bevacizumab by Countries
7.2 Europe Bevacizumab Market Size by Type
7.3 Europe Bevacizumab Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Bevacizumab by Countries
8.2 Middle East & Africa Bevacizumab Market Size by Type
8.3 Middle East & Africa Bevacizumab Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL BEVACIZUMAB MARKET FORECAST

10.1 Global Bevacizumab Market Size Forecast (2019-2024)
10.2 Global Bevacizumab Forecast by Regions
  10.2.1 Global Bevacizumab Forecast by Regions (2019-2024)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Bevacizumab Forecast by Type
10.8 Global Bevacizumab Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Genentech
  11.1.1 Company Details
  11.1.2 Bevacizumab Product Offered
  11.1.3 Genentech Bevacizumab Revenue, Gross Margin and Market Share (2017-2019)
  11.1.4 Main Business Overview
  11.1.5 Genentech News
11.2 Amgen
  11.2.1 Company Details
  11.2.2 Bevacizumab Product Offered
  11.2.3 Amgen Bevacizumab Revenue, Gross Margin and Market Share (2017-2019)
  11.2.4 Main Business Overview
  11.2.5 Amgen News

...

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Bevacizumab
Figure Bevacizumab Report Years Considered
Figure Market Research Methodology
Figure Global Bevacizumab Market Size Growth Rate 2014-2024 ($ Millions)
Table Bevacizumab Market Size CAGR by Region 2014-2024 ($ Millions)
Table Major Players of Avastin (bevacizumab)
Table Major Players of Mvasi (bevacizumab-awwb)
Table Market Size by Type (2014-2019) ($ Millions)
Table Global Bevacizumab Market Size Market Share by Type (2014-2019)
Figure Global Bevacizumab Market Size Market Share by Type (2014-2019)
Figure Global Avastin (bevacizumab) Market Size Growth Rate
Figure Global Mvasi (bevacizumab-awwb) Market Size Growth Rate
Figure Bevacizumab Consumed in Cancer
Figure Global Bevacizumab Market: Cancer (2014-2019) ($ Millions)
Figure Global Cancer YoY Growth ($ Millions)
Figure Bevacizumab Consumed in Eye Diease
Figure Global Bevacizumab Market: Eye Diease (2014-2019) ($ Millions)
Figure Global Eye Diease YoY Growth ($ Millions)
Table Global Bevacizumab Market Size by Application (2014-2019) ($ Millions)
Table Global Bevacizumab Market Size Market Share by Application (2014-2019)
Figure Global Bevacizumab Market Size Market Share by Application (2014-2019)
Figure Global Bevacizumab Market Size in Cancer Growth Rate
Figure Global Bevacizumab Market Size in Eye Diease Growth Rate
Table Global Bevacizumab Revenue by Players (2017-2019) ($ Millions)
Table Global Bevacizumab Revenue Market Share by Players (2017-2019)
Figure Global Bevacizumab Revenue Market Share by Players in 2018
Table Global Bevacizumab Key Players Head office and Products Offered
Table Bevacizumab Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global Bevacizumab Market Size by Regions 2014-2019 ($ Millions)
Table Global Bevacizumab Market Size Market Share by Regions 2014-2019
Figure Global Bevacizumab Market Size Market Share by Regions 2014-2019
Figure Americas Bevacizumab Market Size 2014-2019 ($ Millions)
Figure APAC Bevacizumab Market Size 2014-2019 ($ Millions)
Figure Europe Bevacizumab Market Size 2014-2019 ($ Millions)
Figure Middle East & Africa Bevacizumab Market Size 2014-2019 ($ Millions)
Table Americas Bevacizumab Market Size by Countries (2014-2019) ($ Millions)
Table Americas Bevacizumab Market Size Market Share by Countries (2014-2019)
Figure Americas Bevacizumab Market Size Market Share by Countries in 2018
Table Americas Bevacizumab Market Size by Type (2014-2019) ($ Millions)
Table Americas Bevacizumab Market Size Market Share by Type (2014-2019)
Figure Americas Bevacizumab Market Size Market Share by Type in 2018
Table Americas Bevacizumab Market Size by Application (2014-2019) ($ Millions)
Table Americas Bevacizumab Market Size Market Share by Application (2014-2019)
Figure Americas Bevacizumab Market Size Market Share by Application in 2018
Figure United States Bevacizumab Market Size Growth 2014-2019 ($ Millions)
Figure Canada Bevacizumab Market Size Growth 2014-2019 ($ Millions)
Figure Mexico Bevacizumab Market Size Growth 2014-2019 ($ Millions)
Table APAC Bevacizumab Market Size by Countries (2014-2019) ($ Millions)
Table APAC Bevacizumab Market Size Market Share by Countries (2014-2019)
Figure APAC Bevacizumab Market Size Market Share by Countries in 2018
Table APAC Bevacizumab Market Size by Type (2014-2019) ($ Millions)
Table APAC Bevacizumab Market Size Market Share by Type (2014-2019)
Figure APAC Bevacizumab Market Size Market Share by Type in 2018
Table APAC Bevacizumab Market Size by Application (2014-2019) ($ Millions)
Table APAC Bevacizumab Market Size Market Share by Application (2014-2019)
Figure APAC Bevacizumab Market Size Market Share by Application in 2018
Figure China Bevacizumab Market Size Growth 2014-2019 ($ Millions)
Figure Japan Bevacizumab Market Size Growth 2014-2019 ($ Millions)
Figure Korea Bevacizumab Market Size Growth 2014-2019 ($ Millions)
Figure Southeast Asia Bevacizumab Market Size Growth 2014-2019 ($ Millions)
Figure India Bevacizumab Market Size Growth 2014-2019 ($ Millions)
Figure Australia Bevacizumab Market Size Growth 2014-2019 ($ Millions)
Table Europe Bevacizumab Market Size by Countries (2014-2019) ($ Millions)
Table Europe Bevacizumab Market Size Market Share by Countries (2014-2019)
Figure Europe Bevacizumab Market Size Market Share by Countries in 2018
Table Europe Bevacizumab Market Size by Type (2014-2019) ($ Millions)
Table Europe Bevacizumab Market Size Market Share by Type (2014-2019)
Figure Europe Bevacizumab Market Size Market Share by Type in 2018
Table Europe Bevacizumab Market Size by Application (2014-2019) ($ Millions)
Table Europe Bevacizumab Market Size Market Share by Application (2014-2019)
Figure Europe Bevacizumab Market Size Market Share by Application in 2018
Figure Germany Bevacizumab Market Size Growth 2014-2019 ($ Millions)
Figure France Bevacizumab Market Size Growth 2014-2019 ($ Millions)
Figure UK Bevacizumab Market Size Growth 2014-2019 ($ Millions)
Figure Italy Bevacizumab Market Size Growth 2014-2019 ($ Millions)
Figure Russia Bevacizumab Market Size Growth 2014-2019 ($ Millions)
Figure Spain Bevacizumab Market Size Growth 2014-2019 ($ Millions)
Table Middle East & Africa Bevacizumab Market Size by Countries (2014-2019) ($ Millions)
Table Middle East & Africa Bevacizumab Market Size Market Share by Countries (2014-2019)
Figure Middle East & Africa Bevacizumab Market Size Market Share by Countries in 2018
Table Middle East & Africa Bevacizumab Market Size by Type (2014-2019) ($ Millions)
Table Middle East & Africa Bevacizumab Market Size Market Share by Type (2014-2019)
Figure Middle East & Africa Bevacizumab Market Size Market Share by Type in 2018
Table Middle East & Africa Bevacizumab Market Size by Application (2014-2019) ($ Millions)
Table Middle East & Africa Bevacizumab Market Size Market Share by Application (2014-2019)
Figure Middle East & Africa Bevacizumab Market Size Market Share by Application in 2018
Figure Egypt Bevacizumab Market Size Growth 2014-2019 ($ Millions)
Figure South Africa Bevacizumab Market Size Growth 2014-2019 ($ Millions)
Figure Israel Bevacizumab Market Size Growth 2014-2019 ($ Millions)
Figure Turkey Bevacizumab Market Size Growth 2014-2019 ($ Millions)
Figure GCC Countries Bevacizumab Market Size Growth 2014-2019 ($ Millions)
Figure Global Bevacizumab arket Size Forecast (2019-2024) ($ Millions)
Table Global Bevacizumab Market Size Forecast by Regions (2019-2024) ($ Millions)
Table Global Bevacizumab Market Size Market Share Forecast by Regions
Figure Americas Bevacizumab Market Size 2019-2024 ($ Millions)
Figure APAC Bevacizumab Market Size 2019-2024 ($ Millions)
Figure Europe Bevacizumab Market Size 2019-2024 ($ Millions)
Figure Middle East & Africa Bevacizumab Market Size 2019-2024 ($ Millions)
Figure United States Bevacizumab Market Size 2019-2024 ($ Millions)
Figure Canada Bevacizumab Market Size 2019-2024 ($ Millions)
Figure Mexico Bevacizumab Market Size 2019-2024 ($ Millions)
Figure Brazil Bevacizumab Market Size 2019-2024 ($ Millions)
Figure China Bevacizumab Market Size 2019-2024 ($ Millions)
Figure Japan Bevacizumab Market Size 2019-2024 ($ Millions)
Figure Korea Bevacizumab Market Size 2019-2024 ($ Millions)
Figure Southeast Asia Bevacizumab Market Size 2019-2024 ($ Millions)
Figure India Bevacizumab Market Size 2019-2024 ($ Millions)
Figure Australia Bevacizumab Market Size 2019-2024 ($ Millions)
Figure Germany Bevacizumab Market Size 2019-2024 ($ Millions)
Figure France Bevacizumab Market Size 2019-2024 ($ Millions)
Figure UK Bevacizumab Market Size 2019-2024 ($ Millions)
Figure Italy Bevacizumab Market Size 2019-2024 ($ Millions)
Figure Russia Bevacizumab Market Size 2019-2024 ($ Millions)
Figure Spain Bevacizumab Market Size 2019-2024 ($ Millions)
Figure Egypt Bevacizumab Market Size 2019-2024 ($ Millions)
Figure South Africa Bevacizumab Market Size 2019-2024 ($ Millions)
Figure Israel Bevacizumab Market Size 2019-2024 ($ Millions)
Figure Turkey Bevacizumab Market Size 2019-2024 ($ Millions)
Figure GCC Countries Bevacizumab Market Size 2019-2024 ($ Millions)
Table Global Bevacizumab Market Size Forecast by Type (2019-2024) ($ Millions)
Table Global Bevacizumab Market Size Market Share Forecast by Type (2019-2024)
Table Global Bevacizumab Market Size Forecast by Application (2019-2024) ($ Millions)
Table Global Bevacizumab Market Size Market Share Forecast by Application (2019-2024)
Table Genentech Basic Information, Head Office, Major Market Areas and Its Competitors
Table Genentech Bevacizumab Revenue and Gross Margin (2017-2019)
Figure Genentech Bevacizumab Market Share (2017-2019)
Table Amgen Basic Information, Head Office, Major Market Areas and Its Competitors
Table Amgen Bevacizumab Revenue and Gross Margin (2017-2019)
Figure Amgen Bevacizumab Market Share (2017-2019)